Biopharmaceutical Analysis

Cytomos will use the £4 million in funding to develop its dielectric spectroscopy technology.

Waters XBridge Premier GTx BEH size exclusion chromatography (SEC) columns are designed to improve analysis while lowering the cost of gene therapies.

Advanced analytical tools generate more data in today’s labs than ever before.

Webinar Date/Time: Wednesday, August 9, 2023 at 5pm CEST | 11am EDT | 8am PDT

Webinar Date/Time: Thu, Aug 17, 2023 11:00 AM EDT

Thermo Fisher Scientific’s new tumoroid culture medium kit is designed to help cancer researchers better model the disease.

Eurofins Genomics Blue Heron’s novel mRNA synthesis service is designed for customizable applications.

Considering the differences between small- and large-molecule drug products can help determine analytical testing methods for E&L.

Image analysis algorithms coupled with microscopy techniques can be used to characterize aggregates of therapeutic proteins.

Webinar Date/Time: Tue, Aug 1, 2023 11:00 AM EDT

Sandbox AQ’s molecular simulation division is collaborating with companies like AstraZeneca and Sanofi to develop novel treatments for various disorders.

Charles River’s off-the-shelf lentiviral vector packaging plasmids are intended for use with cell and gene therapies.

Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.

Webinar Date/Time: Thu, Jul 27, 2023 11:00 AM EDT

Analytical characterization of biosimilars plays a crucial role in a successful path to regulatory approval.

ProBioGen’s Lenti.RiGHT is a lentivirus production platform for use in gene transfer applications.

Waters Corporation expected to boost growth in bioanalytical characterization for new modalities with acquisition of Wyatt Technology.

Webinar Date/Time: Wed, Jun 14, 2023 10:00 AM EDT

Webinar Date/Time: Thu, Jun 1, 2023 11:00 AM EDT

Avoiding missteps in data integrity is contingent on the development of a holistic data integrity approach.

Webinar Date/Time: Tue, May 16, 2023 11:00 AM EDT

Preclinical studies specifically benefit from the “smart” drug development trend through deeper data access and analysis.

Webinar Dates/Times: Thursday, June 29, 2023 at 17:00 CEST | 11:00 EDT | 08:00 PDT

Webinar Dates/Times: Session 1 (EU): Wednesday, May 17th, 2023 at 2pm BST | 3pm CEST | 9am EDT Session 2 (NA): Wednesday, May 17th, 2023 at 1pm EDT | 10am PDT | 6pm BST Session 3 (APAC): Thursday, May 18th, 2023 at 12pm JST | 11am CST | 11pm EDT

Monil Malhotra, vice-president of Industrial Software at Emerson, discusses the growing demand for software solutions in the pharma industry.

Ginkgo Bioworks has acquired StrideBio's AAV capsid discovery and engineering platform and has formed a partnership with WARF for development of next-gen cell therapies.

The acquisition of Cell Systems will bolster AnaBios’ portfolio of human tissue and cells for use in drug discovery.

Webinar Date/Time: Wed, May 31, 2023 11:00 AM EDT

Michalle Adkins, director of Life Sciences Consulting at Emerson, discusses the structure of manufacturing organizations and how novel technologies may play a role in operations.

Webinar Date/Time: Wed, May 10, 2023 11:00 AM EDT